Emergent BioSolutions Inc (NYSE:EBS)
$ 5.27 -0.44 (-7.71%) Market Cap: 276.16 Mil Enterprise Value: 1.13 Bil PE Ratio: 0 PB Ratio: 0.42 GF Score: 68/100

Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 08:30PM GMT
Release Date Price: $104.17 (+6.21%)
Albert Hwang;Morgan Stanley;Managing Director

Hi, everybody. Thank you for joining the Emergent BioSolutions fireside chat. This is Albert Hwang from Morgan Stanley speaking. And again, thank you for joining. I have with me Rich Lindahl, the CFO of Emergent; and Bob Burrows, the Head of Investor Relations at Emergent. I will be -- there is no corporate presentation, but you can find it on their website. I will start with a few questions, but if you do have any questions, please feel free to ask them.

So maybe I can start. Rich, if you can give maybe a little bit about your background and then the current state of Emergent. The stock has actually done very well over the past few months. So I'd be curious to hear what you think that's attributed to.

Richard S. Lindahl
Emergent BioSolutions Inc. - Executive VP, CFO & Treasurer

Sure. Thank you very much, Albert, and good afternoon, everyone. Appreciate you taking the time to participate in our fireside chat today. So my name is Rich Lindahl. I'm the CFO of Emergent. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot